Holen Sie sich die Stockscreener-App
4.00
3.09%
0.12
Handel nachbörslich:
4.00
Schlusskurs vom Vortag:
$3.88
Offen:
$4
24-Stunden-Volumen:
1.57M
Relative Volume:
4.13
Marktkapitalisierung:
$461.16M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.50%
1M Leistung:
-4.31%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$3.895
$4.05
1-Wochen-Bereich:
$3.805
$5.19
52-Wochen-Spanne:
$3.60
$5.19
Novabridge Biosciences Adr Stock (NBP) Company Profile
Firmenname
Novabridge Biosciences Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie NBP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NBP
Novabridge Biosciences Adr
|
4.00 | 447.33M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Novabridge Biosciences Adr Stock (NBP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-03 | Eingeleitet | Leerink Partners | Outperform |
| 2025-09-09 | Eingeleitet | BTIG Research | Buy |
| 2021-12-09 | Eingeleitet | Siebert Williams Shank | Buy |
| 2021-06-02 | Eingeleitet | Daiwa Securities | Buy |
| 2021-03-15 | Eingeleitet | Needham | Buy |
| 2021-03-03 | Bestätigt | H.C. Wainwright | Buy |
| 2021-02-25 | Eingeleitet | Piper Sandler | Overweight |
| 2020-12-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-07-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-02-12 | Eingeleitet | China Renaissance | Buy |
| 2020-02-11 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Novabridge Biosciences Adr Aktie (NBP) Neueste Nachrichten
Brookline Capital reiterates Buy rating on NovaBridge stock with $8 target - Investing.com Nigeria
NovaBridge to Ring the Nasdaq Opening Bell on Friday, January 2, 2026 - GlobeNewswire Inc.
Understanding RRC’s financial ratios: A beginner’s guide - uspostnews.com
NovaBridge Biosciences. ADR’s results are impressive - uspostnews.com
Faraday Future Intelligent Electric Inc (FFAI) looking to reclaim success with recent performance - setenews.com
NovaBridge to present extended dosing data for cancer drug ragistomig - Investing.com
Are Smart Investors Making the Right Decision? NovaBridge Biosciences. ADR (NBP) - Setenews
Evercore ISI resumes Aura Biosciences stock coverage with Outperform rating - Investing.com
What is the current Price Target and Forecast for NovaBridge Biosciences (NBP) - Zacks Investment Research
NovaBridge subsidiary Visara appoints two key ophthalmology leaders By Investing.com - Investing.com Nigeria
NovaBridge subsidiary Visara appoints two key ophthalmology leaders - Investing.com India
Investors in cash trouble should check out NovaBridge Biosciences. ADR (NBP) - Setenews
Get in on Motorsport Games Inc’s (MSGM) buy-in window today! - Setenews
This trade activity should not be overlooked: Zooz Strategy Ltd (ZOOZ) - setenews.com
There is no way NovaBridge Biosciences. ADR (NBP) can keep these numbers up - setenews.com
Prepare Yourself for Liftoff: Sandisk Corp (SNDK) - Setenews
NBP Financial Statements & ChartsNovabridge Biosciences.Adr MacroTrends - CMLviz
NBP Interactive Stock ChartNovabridge Biosciences.Adr. Stock Analysis - CMLviz
NBP Pivot Points, Technical Analysis and Moving AveragesNovabridge Biosciences.Adr Technicals - CMLviz
Total equity of NovaBridge Biosciences Sponsored ADR – NASDAQ:NBP - TradingView
Equity in earnings of NovaBridge Biosciences Sponsored ADR – NASDAQ:NBP - TradingView
symbol__ Stock Quote Price and Forecast - CNN
NovaBridge Biosciences Sponsored ADR Earnings and Revenue – NASDAQ:NBP - TradingView — Track All Markets
Long term debt to total assets ratio of NovaBridge Biosciences Sponsored ADR – NASDAQ:NBP - TradingView
NBP Forecast — Price Target — Prediction for 2026 - TradingView
NBP Stock Price and Chart — NASDAQ:NBP - TradingView — Track All Markets
NBPNovaBridge Biosciences. ADR Stock Price and Quote - Finviz
I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NBP) with Trading Effective October 30, 2025 New Brand and Logo to Reflect Strategic Transformation to a Global Biotech Platform - Barchart.com
I-Mab stock reaffirmed as Buy at H.C. Wainwright on positive cancer drug data - Investing.com
I-Mab Rebrands to NovaBridge Biosciences Following Shareholder Approval - TipRanks
I-Mab stock price target raised to $9 from $7 at BTIG on strategic shift - Investing.com
I-Mab to rebrand as NovaBridge Biosciences, plans Hong Kong IPO By Investing.com - Investing.com South Africa
I-Mab to rebrand as NovaBridge Biosciences, plans Hong Kong IPO - Investing.com
Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday - Benzinga
This Bank of New York Mellon Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Why Wolfspeed Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket - Benzinga
C3.ai Posts Downbeat Results, Joins GitLab, Salesforce And Other Big Stocks Moving Lower In Thursday's Pre-Market SessionAcadian Asset Management (NYSE:AAMI), C3.ai (NYSE:AI) - Benzinga
Evolv Technologies, Precigen, Hesai Group And Other Big Stocks Moving Higher On Friday - Benzinga
Kimball Electronics Posts Better-Than-Expected Earnings, Joins Terawulf, Dlocal, Equinox Gold And Other Big Stocks Moving Higher On Thursday - Benzinga
Most VolatileStock ScreenerNews - Finviz
Morningstar’s Best- and Worst-Performing Stocks: 2022 - Morningstar
10 of the Cheapest Stocks of 2022 - Morningstar
The Best- and Worst-Performing Stocks: Q3 2022 - Morningstar
New 5-Star Stocks - Morningstar
ORIC Stock Price | Oric Pharmaceuticals Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch
ADPT Stock Price | Adaptive Biotechnologies Corp. Stock Quote (U.S.: Nasdaq) - MarketWatch
Finanzdaten der Novabridge Biosciences Adr-Aktie (NBP)
Es liegen keine Finanzdaten für Novabridge Biosciences Adr (NBP) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
28.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):